FDA Advisory Panel Calls for More Data on HIFU TreatmentFDA Advisory Panel Calls for More Data on HIFU Treatment
An FDA advisory panel has voted against recommending approval of a high-intensity focused ultrasound treatment for recurrent prostate cancer. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Health | Hematology | High Intensity Focused Ultrasound Therapy | Prostate Cancer | Ultrasound